Company Filing History:
2 out of 35 
2 out of 4,449 
Years Active: 1994-1995
Title: The Innovations of Harry F Dovey
Introduction
Harry F Dovey is a notable inventor based in Pacifica, California. He has made significant contributions to the field of proteolytic enzymes, particularly with his work on amyloidin protease. With a total of two patents to his name, Dovey's innovations have the potential to impact medical research and treatment.
Latest Patents
Dovey's latest patents focus on the amyloidin protease, a proteolytic enzyme isolated from human tissue. This enzyme exhibits the ability to hydrolyze the Met-Asp peptide bond in an amyloid-like substrate. The enzyme is named 'amyloidin' due to its function in cleaving a Met-Asp bond similar to that found in the amyloid precursor protein. This process releases a fragment that has the mature Asp terminus of the beta-amyloid peptide. Additionally, Dovey's patents include antibodies to the amyloidin protease, methods for isolating and purifying the enzyme, and assays to screen for inhibitors. The patents also disclose the gene encoding the protease and methods for its expression through recombinant DNA techniques.
Career Highlights
Throughout his career, Dovey has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Athena Neurosciences, Inc. and Eli Lilly and Company. His work in these organizations has contributed to advancements in neuroscience and therapeutic development.
Collaborations
Dovey has collaborated with esteemed colleagues such as Peter A Seubert and Sukanto Sinha. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Harry F Dovey's contributions to the field of proteolytic enzymes, particularly through his patents on amyloidin protease, showcase his innovative spirit and dedication to advancing medical science. His work continues to hold promise for future research and therapeutic applications.